Back to top

Amgen Inc. (AMGN)

(Real Time Quote from BATS)

$255.64 USD


-0.07 (-0.03%)

Updated Apr 19, 2021 03:54 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
5Strong Sell3.06%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum C VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 23% (196 out of 254)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Company Summary

Thousand Oaks, CA-based Amgen is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health and nephrology and neuroscience markets. The company used advances in cellular and molecular biology to develop two of the biotech industry’s earliest and most successful drugs, Epogen (anemia) and Neupogen (white blood cell stimulant). Amgen successfully launched two next-generation products, Aranesp and Neulasta.  Meanwhile, the acquisition of Immunex Corporation gave Amgen access to the multi-blockbuster drug, Enbrel. However, all these older drugs are facing declining ...

General Information

Amgen Inc.



Phone: 805-447-1000

Fax: 805-447-1010



Industry Medical - Biomedical and Genetics
Sector Medical
Fiscal Year End December
Last Reported Quarter 3/31/2021
Next EPS Date 4/27/2021

EPS Information

Current Quarter EPS Consensus Estimate 4.03
Current Year EPS Consensus Estimate 16.72
Estimated Long-Term EPS Growth Rate 8.40
Next EPS Report Date 4/27/2021

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 255.71
52 Week High 276.69
52 Week Low 210.28
Beta 0.74
20 Day Moving Average 2,084,893.38
Target Price Consensus 259.41


% Price Change
4 Week 4.62
12 Week 1.46
YTD 11.22
% Price Change Relative to S&P 500
4 Week -2.13
12 Week -6.60
YTD -0.19
Share Information
Shares Outstanding (millions) 575.80
Market Capitalization (millions) 147,238.33
Short Ratio NA
Last Split Date 11/22/1999
Dividend Information
Dividend Yield 2.75%
Annual Dividend $7.04
Payout Ratio 0.39
Change in Payout Ratio 0.00
Last Dividend Payout / Amount 2/11/2021 / $1.76

Fundamental Ratios

P/E (F1) 15.29
Trailing 12 Months 15.40
PEG Ratio 1.83
EPS Growth
vs. Previous Year 4.67%
vs. Previous Quarter -12.81%
Sales Growth
vs. Previous Year 7.05%
vs. Previous Quarter 3.29%
Price Ratios
Price/Book 15.82
Price/Cash Flow 11.11
Price / Sales 5.79
3/31/21 NA
12/31/20 96.71
9/30/20 95.55
3/31/21 NA
12/31/20 15.41
9/30/20 15.52
Current Ratio
3/31/21 NA
12/31/20 1.81
9/30/20 2.28
Quick Ratio
3/31/21 NA
12/31/20 1.48
9/30/20 1.88
Operating Margin
3/31/21 NA
12/31/20 38.53
9/30/20 38.98
Net Margin
3/31/21 NA
12/31/20 28.57
9/30/20 29.42
Pre-Tax Margin
3/31/21 NA
12/31/20 31.99
9/30/20 32.97
Book Value
3/31/21 NA
12/31/20 16.16
9/30/20 18.82
Inventory Turnover
3/31/21 NA
12/31/20 1.60
9/30/20 1.55
3/31/21 NA
12/31/20 3.50
9/30/20 3.12
Debt to Capital
3/31/21 NA
12/31/20 77.76
9/30/20 75.73